Providing 690+ products to patients worldwide
We create high-quality medicines, and make them accessible to people who need them. We have a broad product range and a growing pipeline of new medicines for treating a wide range of diseases. Therapeutic categories include anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory.
690+
Products on the market
50+
Countries
3
Distinct businesses
Related news
Hikma provides update on status of ANDA for generic Advair Diskus®
22 September 2020
Hikma launches Azacitidine for Injection
10 September 2020
Hikma launches Dacarbazine for Injection, USP
24 July 2020